XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues        
Total revenues $ 2,096 $ 3,195 $ 6,635 $ 8,866
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Expenses        
Cost of sales $ 799 $ 1,315 $ 2,497 $ 3,235
Research and development 79 616 1,001 1,879
Selling and marketing 626 608 2,057 1,940
General and administrative 1,405 1,319 4,324 4,026
Total expenses 2,909 3,858 9,879 11,080
Loss from operations (813) (663) (3,244) (2,214)
Other income (expense)        
Change in fair value of warrant liability 837 758 1,745 1,092
Interest expense (21) (17) (55) (26)
Miscellaneous income   43 2 45
Total other income (expense), net 816 784 1,692 1,111
Net income (loss) 3 121 (1,552) (1,103)
Net income (loss) applicable to common stockholders $ 3 $ 121 $ (1,552) $ (1,103)
Net income (loss) per common share-basic $ 0.00 $ 0.02 $ (0.21) $ (0.18)
Net income (loss) per common share-diluted $ 0.00 $ 0.02 $ (0.21) $ (0.18)
Weighted average shares-basic 7,546 6,337 7,502 6,233
Weighted average shares-diluted 7,546 6,404 7,502 6,233